iasibon
pharmathen s.a. - ácido ibandrónico - hypercalcemia; fractures, bone; neoplasm metastasis; breast neoplasms - drogas para tratamento de doenças ósseas - concentrate for solution for infusion prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. o tratamento de tumores induzidos por hypercalcaemia com ou sem metástases. film-coated tablets prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.
proleukin
zodiac produtos farmacÊuticos s/a - imunomodulador
idelvion
csl behring gmbh - albutrepenonacog alfa - hemofilia b - anti-hemorrágicos - tratamento e profilaxia do sangramento em pacientes com hemofilia b (deficiência congênita de factor ix).
abraxane
celgene brasil produtos farmacÊuticos ltda. - paclitaxel - agentes antineoplÁsicos
beribumin
csl behring comÉrcio de produtos farmacÊuticos ltda - albumina humana - fracoes do sangue ou plasma exceto gamaglobulina
vialebex
lfb - hemoderivados e biotecnologia ltda - albumina humana - derivados do sangue e substitutos
pul-tec
comissao nacional de energia nuclear - albumina humana - agentes diagnosticos radioativos
eparema
cosmed industria de cosmeticos e medicamentos s.a. - rheum palmatum l., frangula purshiana (dc.) a. gray , peumus boldus molina - fitoterapico composto; colagogos e colereticos
rybrevant
janssen-cilag international n.v. - amivantamab - carcinoma, pulmão de células não pequenas - agentes antineoplásicos - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
kerendia
bayer ag - finerenone - renal insufficiency, chronic; diabetes mellitus, type 2 - agentes que atuam no sistema renina-angiotensina - kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults.